Eitan Friedman

ORCID

Publication Activity (10 Years)

Years Active: 2017-2024
Publications (10 Years): 27

Top Venues

Breast cancer research and treatment

Cancer

Human mutation

Cancers

Karolinska Institutet (PHD)

This page only lists publications with an associated author ORCID identifier.

Education History

Karolinska Institutet Jan 01 1992 - Jun 01 1994

Sweden

PHD :: clinical genetics CMM

Publications

Hila Bufman, Renata Faermann, Osnat Halshtok-Neiman, Anat Shalmon, Michael Gotlieb, David Samoocha, Yael Yagil, Dana Madorsky Feldman, Eitan Friedman, Miri Sklair-Levy
Breast cancer diagnosed after age 70 years in Israeli BRCA1/BRCA2 pathogenic sequence variant carriers: a single institution experience. Breast cancer research and treatment (2024)
Yael Laitman, Anni Niskakoski, Rinal Bernstein-Molho, Lotta Koskinen, Daniel Rabina, Juha Koskenvuo, Eitan Friedman
Phenotypes of carriers of two mutated alleles in major cancer susceptibility genes. Breast cancer research and treatment (2024)
Hila Bufman, Renata Faermann, Osnat Halshtok-Neiman, Anat Shalmon, Michael Gotlieb, David Samoocha, Yael Yagil, Dana Madorsky Feldman, Eitan Friedman, Miri Sklair-Levy
Breast cancer diagnosed after age 70 years in Israeli BRCA1/BRCA2 pathogenic sequence variant carriers: a single institution experience. Breast cancer research and treatment 205 (2) (2024)
Hila Bufman, Renata Faermann, Osnat Halshtok-Neiman, Anat Shalmon, Michael Gotlieb, David Samoocha, Yael Yagil, Dana Madorsky Feldman, Eitan Friedman, Miri Sklair-Levy
Breast cancer diagnosed after age 70 years in Israeli BRCA1/BRCA2 pathogenic sequence variant carriers: a single institution experience. Breast cancer research and treatment 205 (2) (2024)
Hila Bufman, Renata Faermann, Osnat Halshtok-Neiman, Anat Shalmon, Michael Gotlieb, David Samoocha, Yael Yagil, Dana Madorsky Feldman, Eitan Friedman, Miri Sklair-Levy
Breast cancer diagnosed after age 70 years in Israeli BRCA1/BRCA2 pathogenic sequence variant carriers: a single institution experience. Breast cancer research and treatment 205 (2) (2024)
Hila Bufman, Renata Faermann, Osnat Halshtok-Neiman, Anat Shalmon, Michael Gotlieb, David Samoocha, Yael Yagil, Dana Madorsky Feldman, Eitan Friedman, Miri Sklair-Levy
Breast cancer diagnosed after age 70 years in Israeli BRCA1/BRCA2 pathogenic sequence variant carriers: a single institution experience. Breast cancer research and treatment 205 (2) (2024)
Debbie Anaby, David Shavin, Gali Zimmerman-Moreno, Noam Nissan, Eitan Friedman, Miri Sklair-Levy
'Earlier than Early' Detection of Breast Cancer in Israeli BRCA Mutation Carriers Applying AI-Based Analysis to Consecutive MRI Scans. Cancers 15 (12) (2023)
Debbie Anaby, David Shavin, Gali Zimmerman-Moreno, Noam Nissan, Eitan Friedman, Miri Sklair-Levy
'Earlier than Early' Detection of Breast Cancer in Israeli BRCA Mutation Carriers Applying AI-Based Analysis to Consecutive MRI Scans. Cancers 15 (12) (2023)
Maya Ben Lassan, Yael Laitman, Lital Keinan-Boker, Barbara Silverman, Eitan Friedman
Secondary cancer after meningioma diagnosis: an Israeli national study. Cancer causes & control : CCC 33 (10) (2022)
Renata Faermann, Eitan Friedman, Orit Kaidar Person, Jonathan Weidenfeld, Malka Brodsky, Anat Shalmon, Osnat Halshtok Neiman, Michael Gotlieb, Yael Yagil, David Samoocha, Dana Madorsky Feldman, Miri Sklair-Levy
Ductal Carcinoma In Situ (DCIS) Diagnosed by MRI-Guided Biopsy among <i>BRCA1/BRCA2</i> Mutation Carriers. The breast journal 2022 (2022)
Meghna S Trivedi, Nadir Arber, Eitan Friedman, Judy E Garber, Kevin Holcomb, Neil S Horowitz, Jason D Wright, Jiun-Kae Jack Lee, Lana A Vornik, Saba Abutaseh, Tawana Castile, Edward R Sauter, Eileen Dimond, Brandy M Heckman-Stoddard, Margaret House, Goli Samimi, Powel H Brown, Katherine D Crew
Lessons from the Failure to Complete a Trial of Denosumab in Women With a Pathogenic BRCA1/2 Variant Scheduling Risk-Reducing Salpingo-Oophorectomy. Cancer prevention research (Philadelphia, Pa.) 15 (11) (2022)
Yael Laitman, Sarah M Nielsen, Rinat Bernstein-Molho, Brandie Heald, Kathryn E Hatchell, Edward D Esplin, Eitan Friedman
Cancer risks associated with heterozygous ATM loss of function and missense pathogenic variants based on multigene panel analysis. Breast cancer research and treatment 196 (2) (2022)
Cecilia Castillo-Leska, Nora Artagaveytia, Lucia Brignoni, Yael Laitman, Natalia Camejo-Martínez, Ana Laura Hernández, Gabriel Krygier, Alfonso Cayota, Lucia Delgado, Eitan Friedman
Population-based screening of Uruguayan Ashkenazi Jews for recurrent BRCA1 and BRCA2 pathogenic sequence variants. Molecular genetics & genomic medicine 10 (6) (2022)
Hagit Shani, Rinat Bernstein-Molho, Yael Laitman, Iris Netzer, Eitan Friedman
Double heterozygosity for TP53 and BRCA1 mutations: clinical implications in populations with founder mutations. Breast cancer research and treatment 186 (1) (2021)
Yael Laitman, Sarah M Nielsen, Kathryn E Hatchell, Rebecca Truty, Rinat Bernstein-Molho, Edward D Esplin, Eitan Friedman
Re-evaluating cancer risks associated with the CHEK2 p.Ser428Phe Ashkenazi Jewish founder pathogenic variant. Familial cancer (2021)
Rinat Bernstein Molho, Lee Galmor, Yael Laitman, Shlomo Segev, Eitan Friedman
Yield of targeted genotyping for the recurring pathogenic variants in cancer susceptibility genes in a healthy, multiethnic Israeli population. Cancer 127 (19) (2021)
Yael Goldberg, Yael Laitman, Merav Ben David, Lily Bazak, Gabriel Lidzbarsky, Lina B Salmon, Shiri Shkedi-Rafid, Iris Barshack, Camila Avivi, Malak Darawshe, Noam Shomron, Revital Bruchim, Chana Vinkler, Drakoulis Yannoukakos, Florentia Fostira, Rinat Bernstein-Molho, Eitan Friedman
Re-evaluating the pathogenicity of the c.783+2T>C BAP1 germline variant. Human mutation 42 (5) (2021)
Lee Galmor, Rinat Bernstein-Molho, Miri Sklair-Levy, Dana Madoursky-Feldman, Dov Zippel, Yael Laitman, Eitan Friedman
Time trends in uptake rates of risk-reducing mastectomy in Israeli asymptomatic BRCA1 and BRCA2 mutation carriers. Breast cancer research and treatment 185 (2) (2020)
Halpern Naama, Albert Grinshpun, Ben Boursi, Talia Golan, Ofer Margalit, Dan Aderka, Eitan Friedman, Yael Laitman, Ayala Hubert, Luna Kadouri, Tamar Hamburger, Inbal Barnes-Kedar, Zohar Levi, Irit Ben-Aharon, Baruch Brenner, Yael Goldberg, Tamar Peretz, Einat Shacham-Shmueli
Clinical Characteristics and Prognosis of Gastric Cancer Patients with BRCA 1/2 Germline Mutations: Report of Ten Cases and a Literature Review. OncoTargets and therapy 13 (2020)
Amit Tirosh, Dexter X Jin, Luiz Armando de Marco, Yael Laitman, Eitan Friedman
Activating genomic alterations in the Gs alpha gene (GNAS) in 274 694 tumors. Genes, chromosomes & cancer 59 (9) (2020)
Yael Laitman, Shay Tzur, Ruben Attai, Amit Tirosh, Eitan Friedman
Germline variant in REXO2 is a novel candidate gene in familial pheochromocytoma. Genetics research 102 (2020)
Yael Laitman, Tara M Friebel, Drakoulis Yannoukakos, Florentia Fostira, Irene Konstantopoulou, Gisella Figlioli, Bernardo Bonanni, Siranoush Manoukian, Monica Zuradelli, Carlo Alberto Tondini, Barbara Pasini, Paolo Peterlongo, Dijana Plaseska-Karanfilska, Milena Jakimovska Özdemir, Keivan Majidzadeh-A, Shiva Zarinfam, Maria A Loizidou, Andreas Hadjisavvas, Kyriaki Michailidou, Kyriacos Kyriacou, Doron M Behar, Rinat Bernstein Molho, Patricia A Ganz, Paul A James, Michael T Parsons, Aminah Sallam, Olufunmilayo I Olopade, Arun Seth, Georgia Chenevix-Trench, Goska Leslie, Lesley McGuffog, Makia J Marafi, Andre Megarbane, Fahd Al-Mulla, Timothy R Rebbeck, Eitan Friedman
The spectrum of BRCA1 and BRCA2 pathogenic sequence variants in Middle Eastern, North African, and South European countries. Human mutation 40 (11) (2019)
Hagit Schayek, Hila Korach, Yael Laitman, Rinat Bernstein-Molho, Eitan Friedman
Mutational analysis of candidate genes in Israeli male breast cancer cases. Breast cancer research and treatment 170 (2) (2018)
Yael Laitman, Rachel Michaelson-Cohen, Einat Levi, Rakefet Chen-Shtoyerman, Orit Reish, Sagi Josefsberg Ben-Yehoshua, Rinat Bernstein-Molho, Lital Keinan-Boker, Ora Rosengarten, Barbara G Silverman, Tamar Perri, Jacob Korach, Pnina Mor, Noa Ephrat Ben-Baruch, Ephrat Levy Lahad, Eitan Friedman, null null
Uterine cancer in Jewish Israeli BRCA1/2 mutation carriers. Cancer 125 (5) (2018)
Limor Helpman, Omri Zidan, Eitan Friedman, Sarit Kalfon, Tamar Perri, Gilad Ben-Baruch, Jacob Korach
Young Israeli women with epithelial ovarian cancer: prevalence of BRCA mutations and clinical correlates. Journal of gynecologic oncology 28 (5) (2017)
Jamal Zidan, Alicia Y Zhou, Jeroen van den Akker, Yael Laitman, Hagit Schayek, Julia Schnaider, Eitan Friedman
Inherited predisposition to breast and ovarian cancer in non-Jewish populations in Israel. Breast cancer research and treatment 166 (3) (2017)
Martin Leclerc, Susan L Neuhausen, Hagit Schayek, Yael Laitman, Antoniou C Antonis, Eitan Friedman
Are VNTRs co-localizing with breast cancer-associated SNPs? Breast cancer research and treatment 168 (1) (2017)

Eitan Friedman.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Eitan Friedman